CEO of Vivida, Entrepreneur Doctor⚕️ | Fitness enthusiast 💪 | Compassionate nurse | Mastering the art of business 📈 Email me📩 and visit website below👇🏼
The answer is definitely A) Metformin + empagliflozin! SGLT2 inhibitors like empagliflozin provide massive cardioprotective benefits, especially for heart failure and MACE reduction.
Which landmark clinical trial famously proved the cardiovascular mortality benefits of empagliflozin? 📉
Q. Which combination is particularly useful for type 2 diabetes with cardiovascular benefit?
A) Metformin + empagliflozin.
B) Metformin + glyburide.
C) Insulin + propranolol.
D) Acarbose + glucagon.
The answer is definitely A) Metformin + empagliflozin! SGLT2 inhibitors like empagliflozin provide massive cardioprotective benefits, especially for heart failure and MACE reduction.
Which landmark clinical trial famously proved the cardiovascular mortality benefits of empagliflozin? 📉